79 related articles for article (PubMed ID: 2520156)
1. Laboratory detection of the early stages of diabetic nephropathy.
Perusicová J; Skrha J; Márová E; Skachová J
Acta Univ Carol Med (Praha); 1989; 35(7-8):265-73. PubMed ID: 2520156
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
Minakami H
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
[TBL] [Abstract][Full Text] [Related]
4. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
5. [Excretion of beta-N-acetylglucosaminidase in urine in type I and type II diabetic patients with and without nephropathy].
Werle E; Bostedt A; Fiehn W; Hasslacher C
Wien Klin Wochenschr Suppl; 1991; 189():59-62. PubMed ID: 1962487
[TBL] [Abstract][Full Text] [Related]
6. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
[TBL] [Abstract][Full Text] [Related]
7. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy.
Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599
[TBL] [Abstract][Full Text] [Related]
8. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.
Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ
Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542
[TBL] [Abstract][Full Text] [Related]
10. [Albuminuria and N-acetyl-beta-glucosaminidase activity in a prospective study of type I diabetics].
Skrha J; Sperl M; Stolba P; Hilgertová J; Stibor V
Vnitr Lek; 1993 Jul; 39(7):699-705. PubMed ID: 8372466
[TBL] [Abstract][Full Text] [Related]
11. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
[TBL] [Abstract][Full Text] [Related]
12. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
Mitic B; Lazarevic G; Vlahovic P; Rajic M; Stefanovic V
Ren Fail; 2008; 30(9):896-903. PubMed ID: 18925530
[TBL] [Abstract][Full Text] [Related]
14. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].
Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E
An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872
[TBL] [Abstract][Full Text] [Related]
15. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of urinary excretion of N-acetyl-beta-glucosaminidase in diabetic retinopathy].
Garbín Fuentes I ; Pérez Blanco FJ ; Pérez Chica G ; Moreno Terribas G ; Rodríguez Cuartero A ; Avilés Puigvert M
Arch Soc Esp Oftalmol; 2000 Dec; 75(12):791-5. PubMed ID: 11151274
[TBL] [Abstract][Full Text] [Related]
17. N-Acetyl-beta-D-glucosaminidase levels and the onset of diabetic microangiopathy.
Whiting PH; Ross IS; Borthwick LJ
Ann Clin Biochem; 1983 Jan; 20 Pt 1():15-9. PubMed ID: 6838142
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and diagnostic significance of microalbuminuria and activity of tubular enzyme N-acetyl-beta-D-glucosaminidase (NAG) determination in patients with hyperuricosuria].
Lebedeva MV; Balkarov IM; Lukicheva TI; Men'shikov VV; Mukhin NA; Varshavskĭ VA; Proskurneva EP; Aleksandrovaskaia TN
Ter Arkh; 1998; 70(4):48-54. PubMed ID: 9612904
[TBL] [Abstract][Full Text] [Related]
19. [Microalbumin and N-acetyl-beta-D-glucosaminidase in random spot urine samples as predictors of diabetic nephropathy in the elderly non-insulin dependent diabetic patients].
Hirai M; Nakano H; Oba K; Metori S
Nihon Ika Daigaku Zasshi; 1997 Dec; 64(6):518-25. PubMed ID: 9436372
[TBL] [Abstract][Full Text] [Related]
20. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO; Jeffers BW; Gifford N; Schrier RW
Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
